Skip to main content
Top
Published in: World Journal of Surgery 8/2004

01-08-2004 | Original Scientific Reports

Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior

Authors: Mark Hartel, M.D., Fabio F. di Mola, M.D., Andrea Gardini, M.D., Arthur Zimmermann, Ph.D., Pierluigi Di Sebastiano, M.D., Ahmed Guweidhi, M.D., Paolo Innocenti, M.D., Thomas Giese, M.D., Nathalia Giese, M.D., Markus W. Büchler, M.D., Helmut Friess, M.D.

Published in: World Journal of Surgery | Issue 8/2004

Login to get access

Abstract

Connective tissue growth factor (CTGF), which is regulated by transforming growth factor-ß (TGFß), has recently been implicated in the pathogenesis of fibrotic diseases and tumor stroma. Inasmuch as generation of desmoplastic tissue is characteristic for pancreatic cancer, it is not known whether it gives pancreatic cancer cells a growth advantage or is a reaction of the body to inhibit cancer cell progression. In the present study we analyzed the expression and localization of CTGF and evaluated whether it influences the prognosis of pancreas cancer. Tissue samples were obtained from 25 individuals (6 women, 19 men) undergoing pancreatic resection for pancreatic cancer. Tissue samples from 13 previously healthy organ donors (5 women, 8 men) served as controls. Expression of CTGF was studied by Northern blot analysis. In situ hybridization and immunohistochemistry localized the respective mRNA moieties and proteins in the tissue samples. Northern blot analysis revealed that pancreatic cancer tissue samples exhibited a 46-fold increase in CTGF mRNA expression (p < 0.001) over that of normal controls. In vitro studies confirmed that pancreatic stellate cells are the major source of CTGF mRNA expression and revealed a large variance in basal and TGFß-induced CTGF expression in cultured pancreatic cancer cells. This could also be confirmed by in situ hybridization, indicating that CTGF mRNA signals were located principally in fibroblasts, with only weak signals in the cancer cells. High CTGF mRNA levels in the tissue samples correlated with better tumor differentiation (p < 0.03). In addition, patients whose tumors exhibited high CTGF mRNA levels (> onefold increase above normal controls) lived significantly longer than those whose tumors expressed low CTGF mRNA levels (none to onefold) (p < 0.04 multivariate analysis). Our present data indicate that CTGF, as a downstream mediator of TGFß, is overexpressed in connective tissue cells and to a lesser extent in pancreatic cancer cells. Because patients with high CTGF mRNA expression levels have a better prognosis, our findings indicate that the desmoplastic reaction provides a growth disadvantage for pancreatic cancer cells.
Literature
1.
go back to reference Gudjonsson, B 1987Cancer of the pancreas: 50 years of surgeryCancer6022842303PubMed Gudjonsson, B 1987Cancer of the pancreas: 50 years of surgeryCancer6022842303PubMed
2.
go back to reference Parker, GA, Postlethwait, RW 1985The continuing problem of carcinoma of the pancreasJ. Surg. Oncol.283638PubMed Parker, GA, Postlethwait, RW 1985The continuing problem of carcinoma of the pancreasJ. Surg. Oncol.283638PubMed
3.
go back to reference National Cancer Institute. Annual Cancer Statistics Review 1973-1988 (NIH Publ. No. 91-2789), Bethesda, Department of Health and Human Services, 1991 National Cancer Institute. Annual Cancer Statistics Review 1973-1988 (NIH Publ. No. 91-2789), Bethesda, Department of Health and Human Services, 1991
4.
go back to reference Swedish Cancer Registry. Cancer Incidence in Sweden 1988, Stockholm, National Board of Health and Welfare, 1991 Swedish Cancer Registry. Cancer Incidence in Sweden 1988, Stockholm, National Board of Health and Welfare, 1991
5.
go back to reference Arguedas, MR, Heudebert, GH, Stinnett, AA, et al. 2002Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysisAm. J. Gastroenterol.97898904PubMed Arguedas, MR, Heudebert, GH, Stinnett, AA,  et al. 2002Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysisAm. J. Gastroenterol.97898904PubMed
6.
go back to reference Wanebo, HJ, Glicksman, AS, Vezeridis, MP, et al. 2000Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancerArch. Surg.1358187CrossRefPubMed Wanebo, HJ, Glicksman, AS, Vezeridis, MP,  et al. 2000Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancerArch. Surg.1358187CrossRefPubMed
7.
go back to reference Bramhall, SR, Neoptolemus, JP 1997Adjuvant chemotherapy in pancreatic cancerInt. J. Pancreatol.215963PubMed Bramhall, SR, Neoptolemus, JP 1997Adjuvant chemotherapy in pancreatic cancerInt. J. Pancreatol.215963PubMed
8.
go back to reference Farrow, B, Evers, BM 2002Inflammation and the development of pancreatic cancerSurg. Oncol.10153169CrossRefPubMed Farrow, B, Evers, BM 2002Inflammation and the development of pancreatic cancerSurg. Oncol.10153169CrossRefPubMed
9.
go back to reference Nishimura, Y, Hosotani, R, Shibamoto, Y, et al. 1997External and intra-operative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complicationsInt. J. Radiat. Oncol. Biol. Phys.393949CrossRefPubMed Nishimura, Y, Hosotani, R, Shibamoto, Y,  et al. 1997External and intra-operative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complicationsInt. J. Radiat. Oncol. Biol. Phys.393949CrossRefPubMed
10.
go back to reference Friess, H, Büchler, M, Kruger, M, et al. 1992Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelinPancreas7516521PubMed Friess, H, Büchler, M, Kruger, M,  et al. 1992Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelinPancreas7516521PubMed
11.
go back to reference Andrén-Sandberg, Å, Hoem, D, Backman, PL 1999Other risk factors for pancreatic cancer: hormonal aspectsAnn. Oncol.10131135CrossRefPubMed Andrén-Sandberg, Å, Hoem, D, Backman, PL 1999Other risk factors for pancreatic cancer: hormonal aspectsAnn. Oncol.10131135CrossRefPubMed
12.
go back to reference Friess, H, Büchler, M, Beglinger, C, et al. 1993Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancerPancreas8540545PubMed Friess, H, Büchler, M, Beglinger, C,  et al. 1993Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancerPancreas8540545PubMed
13.
go back to reference Beger, HG, Büchler, MW, Friess, H 1994Chirurgische Ergebnisse und Indikation zu adjuvanten Massnahmen beim PankreaskarzinomChirurg65246252PubMed Beger, HG, Büchler, MW, Friess, H 1994Chirurgische Ergebnisse und Indikation zu adjuvanten Massnahmen beim PankreaskarzinomChirurg65246252PubMed
14.
go back to reference Büchler, M, Friess, H, Schultheiss, KH, et al. 1991A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer6815071512PubMed Büchler, M, Friess, H, Schultheiss, KH,  et al. 1991A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer6815071512PubMed
15.
go back to reference Wenger, C, Ellenrieder, V, Alber, B, et al. 1999Expression and differential regulation of connective tissue growth factor in pancreatic cancer cellsOncogene1810731080CrossRefPubMed Wenger, C, Ellenrieder, V, Alber, B,  et al. 1999Expression and differential regulation of connective tissue growth factor in pancreatic cancer cellsOncogene1810731080CrossRefPubMed
16.
go back to reference Ryseck, RP, Macdonald, BH, Mattei, MG, et al. 1991Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich proteinCell Growth Differ.2225233PubMed Ryseck, RP, Macdonald, BH, Mattei, MG,  et al. 1991Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich proteinCell Growth Differ.2225233PubMed
17.
go back to reference Battegay, EJ, Raines, EW, Seifert, RA, et al. 1990TGF-ß induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loopCell63515524CrossRefPubMed Battegay, EJ, Raines, EW, Seifert, RA,  et al. 1990TGF-ß induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loopCell63515524CrossRefPubMed
18.
go back to reference Frazier, K, Williams, S, Kothapalli, D, et al. 1996Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factorJ. Invest. Dermatol.107404411CrossRefPubMed Frazier, K, Williams, S, Kothapalli, D,  et al. 1996Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factorJ. Invest. Dermatol.107404411CrossRefPubMed
19.
go back to reference Grotendorst, GR, Okochi, H, Hayashi, N 1996A novel transforming growth factor-ß response element controls the expression of the connective tissue growth factor geneCell Growth Differ.7469480PubMed Grotendorst, GR, Okochi, H, Hayashi, N 1996A novel transforming growth factor-ß response element controls the expression of the connective tissue growth factor geneCell Growth Differ.7469480PubMed
20.
go back to reference Hishikawa, K, Oemar, BS, Tanner, FC, et al. 1999Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7J. Biol. Chem.2743746137466CrossRefPubMed Hishikawa, K, Oemar, BS, Tanner, FC,  et al. 1999Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7J. Biol. Chem.2743746137466CrossRefPubMed
21.
go back to reference Koliopanos, A, Friess, H, Mola, FF, et al. 2002Connective tissue growth factor gene expression alters tumor progression in esophageal cancerWorld J. Surg.26420427CrossRefPubMed Koliopanos, A, Friess, H, Mola, FF,  et al. 2002Connective tissue growth factor gene expression alters tumor progression in esophageal cancerWorld J. Surg.26420427CrossRefPubMed
22.
go back to reference Oemar, BS, Werner, A, Garnier, J-M, et al. 1997Human connective tissue growth factor is expressed in advanced atherosclerotic lesionsCirculation95831839PubMed Oemar, BS, Werner, A, Garnier, J-M,  et al. 1997Human connective tissue growth factor is expressed in advanced atherosclerotic lesionsCirculation95831839PubMed
23.
go back to reference Friess, H, Zhu, ZW, Mola, FF, et al. 1999Nerve growth factor and its high-affinity receptor in chronic pancreatitisAnn. Surg.230615624CrossRefPubMed Friess, H, Zhu, ZW, Mola, FF,  et al. 1999Nerve growth factor and its high-affinity receptor in chronic pancreatitisAnn. Surg.230615624CrossRefPubMed
24.
go back to reference Friess, H, Lu, Z, Andrén-Sandberg, Å, et al. 1998Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancerAnn. Surg.228780787CrossRefPubMed Friess, H, Lu, Z, Andrén-Sandberg, Å,  et al. 1998Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancerAnn. Surg.228780787CrossRefPubMed
25.
go back to reference Zhu, Z, Friess, H, Mola, FF, et al. 1999Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancerJ. Clin. Oncol.1724192428PubMed Zhu, Z, Friess, H, Mola, FF,  et al. 1999Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancerJ. Clin. Oncol.1724192428PubMed
26.
go back to reference Friess, H, Guo, XZ, Berberat, P, et al. 1998Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastasesInt. J. Cancer79349355CrossRefPubMed Friess, H, Guo, XZ, Berberat, P,  et al. 1998Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastasesInt. J. Cancer79349355CrossRefPubMed
27.
go back to reference Friess, H, Cantero, D, Graber, H, et al. 1997Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesisGastroenterology113904913PubMed Friess, H, Cantero, D, Graber, H,  et al. 1997Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesisGastroenterology113904913PubMed
28.
go back to reference Mola, FF, Friess, H, Martignoni, ME, et al. 1999Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitisAnn. Surg.2306371CrossRefPubMed Mola, FF, Friess, H, Martignoni, ME,  et al. 1999Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitisAnn. Surg.2306371CrossRefPubMed
29.
go back to reference Mola, FF, Friess, H, Riesle, E, et al. 2002Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitisAnn. Surg.2356067CrossRefPubMed Mola, FF, Friess, H, Riesle, E,  et al. 2002Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitisAnn. Surg.2356067CrossRefPubMed
30.
go back to reference Brigstock, DR, Steffen, CL, Kim, GY, et al. 1997Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids: identification as heparin-regulated Mr 10,000 forms of connective tissue growth factorJ. Biol. Chem.2722027520282CrossRefPubMed Brigstock, DR, Steffen, CL, Kim, GY,  et al. 1997Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids: identification as heparin-regulated Mr 10,000 forms of connective tissue growth factorJ. Biol. Chem.2722027520282CrossRefPubMed
31.
go back to reference Hosmer, DW, Lemeshow, S 2000Applied Logistic RegressionWileyNew York Hosmer, DW, Lemeshow, S 2000Applied Logistic RegressionWileyNew York
32.
go back to reference Norusis, MJ 1998SPSS/PC+ User’s GuideVersion 8.0SPSSChicago Norusis, MJ 1998SPSS/PC+ User’s GuideVersion 8.0SPSSChicago
33.
go back to reference Friess, H, Yamanaka, Y, Büchler, M, et al. 1993Enhanced expression of transforming growth factor-ß isoforms in pancreatic cancer correlates with decreased survivalGastroenterology10518461856PubMed Friess, H, Yamanaka, Y, Büchler, M,  et al. 1993Enhanced expression of transforming growth factor-ß isoforms in pancreatic cancer correlates with decreased survivalGastroenterology10518461856PubMed
34.
go back to reference Kleeff, J, Ishiwata, T, Maruyama, H, et al. 1999The TGF-ß signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene1853635372CrossRefPubMed Kleeff, J, Ishiwata, T, Maruyama, H,  et al. 1999The TGF-ß signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene1853635372CrossRefPubMed
35.
go back to reference Friess, H, Yamanaka, Y, Büchler, M, et al. 1993Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expressionCancer Res.5327042707PubMed Friess, H, Yamanaka, Y, Büchler, M,  et al. 1993Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expressionCancer Res.5327042707PubMed
36.
go back to reference Kleeff, J, Korc, M 1998Up-regulation of transforming growth factor TGF-ß receptors by TGF-ß1 in COLO-357 cellsJ. Biol. Chem.27374957500CrossRefPubMed Kleeff, J, Korc, M 1998Up-regulation of transforming growth factor TGF-ß receptors by TGF-ß1 in COLO-357 cellsJ. Biol. Chem.27374957500CrossRefPubMed
37.
go back to reference Kleeff, J, Maruyama, H, Friess, H, et al. 1999Smad-6 suppresses TGF-ß-induced growth inhibition in COLO-357 pancreatic cancer cells and is over-expressed in pancreatic cancerBiochem. Biophys. Res. Commun.255268273CrossRefPubMed Kleeff, J, Maruyama, H, Friess, H,  et al. 1999Smad-6 suppresses TGF-ß-induced growth inhibition in COLO-357 pancreatic cancer cells and is over-expressed in pancreatic cancerBiochem. Biophys. Res. Commun.255268273CrossRefPubMed
Metadata
Title
Desmoplastic Reaction Influences Pancreatic Cancer Growth Behavior
Authors
Mark Hartel, M.D.
Fabio F. di Mola, M.D.
Andrea Gardini, M.D.
Arthur Zimmermann, Ph.D.
Pierluigi Di Sebastiano, M.D.
Ahmed Guweidhi, M.D.
Paolo Innocenti, M.D.
Thomas Giese, M.D.
Nathalia Giese, M.D.
Markus W. Büchler, M.D.
Helmut Friess, M.D.
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 8/2004
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-004-7147-4

Other articles of this Issue 8/2004

World Journal of Surgery 8/2004 Go to the issue